Question 1

What is the active ingredient in SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT?

Accepted Answer

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 /  LP.8.1 VARIANT

Question 2

What pharmaceutical form is SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT available in?

Accepted Answer

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT: Emulsie voor injectie (Intramusculair gebruik)

Question 3

Who manufactures SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT?

Accepted Answer

Hipra Human Health, S.L.U. (NL)

Question 4

What ATC class does SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT belong to?

Accepted Answer

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT: ATC J07BN04. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT

User Reviews